For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

The Trump administration has resumed collection efforts on student loans, affecting those in default sooner than expected.

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

Businesses are struggling with the high cost of healthcare benefits ... disability and absence data can help employers understand ROI from a productivity perspective. Understanding the cost of GLP ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

NurExone Biologic Inc. ("NurExone" or the "Company"), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is deepening its engagement with ...

Members of Congress are back in Washington, and Republicans are struggling to find ways to reduce Medicaid spending without ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

Bariatric surgery and GLP-1s conferred similar outcomes in mortality, adverse cardiovascular events and cirrhosis development ...

As weight loss medications, including Ozempic and WeGovy, have gained popularity across the U.S., they are not without side effects, some serious. According to a May 2024 CNN report, as many as 1 in 8 ...